MARKET WIRE NEWS

CalciMedica Inc. (NASDAQ : CALC ) Stock

Share:

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.


Description


CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure.


Quote


Last:$0.6904
Change Percent: 12.26%
Open:$0.658
Close:$0.615
High:$0.708
Low:$0.6301
Volume:363,481
Last Trade Date Time:03/06/2026 12:41:43 pm

Stock Data


Market Cap:$10,616,869
Float:6,613,929
Insiders Ownership:0.01%
Institutions:18
Short Percent:N/A
Industry:Biotechnology & Life Sciences
Sector:Healthcare
Website:https://www.calcimedica.com
Country:US
City:La Jolla

Recent News Releases


Subscribe to Our Newsletter


Message Board Posts


**MWN-AI FAQ is based on asking OpenAI questions about CalciMedica Inc. (NASDAQ: CALC).

Link Market Wire News to Your X Account

Download The Market Wire News App